These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 12193093
21. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Christensen JH, Riahi S, Schmidt EB, Mølgaard H, Kirstein Pedersen A, Heath F, Cosedis Nielsen J, Toft E. Europace; 2005 Jul; 7(4):338-44. PubMed ID: 15944091 [Abstract] [Full Text] [Related]
22. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators. J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332 [Abstract] [Full Text] [Related]
23. Direct enzyme immunometric measurement of plasma big endothelin-I concentrations and correlation with indicators of left ventricular function. Haug C, Koenig W, Hoeher M, Kochs M, Hombach V, Gruenert A, Osterhues H. Clin Chem; 1998 Feb 06; 44(2):239-43. PubMed ID: 9474018 [Abstract] [Full Text] [Related]
24. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, Muller JE, Mittleman MA, TOVA Investigators. J Am Coll Cardiol; 2007 Dec 04; 50(23):2233-40. PubMed ID: 18061071 [Abstract] [Full Text] [Related]
25. Production and secretion of endothelin by hepatocellular carcinoma. Ishibashi M, Fujita M, Nagai K, Kako M, Furue H, Haku E, Osamura Y, Yamaji T. J Clin Endocrinol Metab; 1993 Feb 04; 76(2):378-83. PubMed ID: 7679399 [Abstract] [Full Text] [Related]
26. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators. J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671 [Abstract] [Full Text] [Related]
27. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. J Heart Lung Transplant; 2009 Jul 03; 28(7):733-5. PubMed ID: 19560703 [Abstract] [Full Text] [Related]
28. The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). Masson S, Latini R, Anand IS, Barlera S, Judd D, Salio M, Perticone F, Perini G, Tognoni G, Cohn JN, Val-HeFT investigators. J Card Fail; 2006 Jun 03; 12(5):375-80. PubMed ID: 16762801 [Abstract] [Full Text] [Related]
29. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chen RH, Chen KP, Wang FZ, Hua W, Chen X, Zhang S. Chin Med J (Engl); 2006 Apr 05; 119(7):557-63. PubMed ID: 16620696 [Abstract] [Full Text] [Related]
30. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). Frantz RP, Lowes BD, Grayburn PA, White M, Krause-Steinrauf H, Krishnan V, Uyeda L, Burnett JC, BEST Neurohumoral Substudy Investigators. J Card Fail; 2007 Aug 05; 13(6):437-44. PubMed ID: 17675057 [Abstract] [Full Text] [Related]
34. [Peripheral plasma Big endothelin 1 levels in patients with gastric carcinoma undergoing radical gastrectomy and its relationship with tumor recurrence]. Teng XJ, Shen ZX, Xiang JJ, Shen L, Yuan L, Guo J, Wang XL. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan 05; 9(1):34-7. PubMed ID: 16437368 [Abstract] [Full Text] [Related]
36. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
37. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators. J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248 [Abstract] [Full Text] [Related]
38. Increased plasma levels of big-endothelin-2 and big-endothelin-3 in patients with end-stage renal disease. Miyauchi Y, Sakai S, Maeda S, Shimojo N, Watanabe S, Honma S, Kuga K, Aonuma K, Miyauchi T. Life Sci; 2012 Oct 15; 91(13-14):729-32. PubMed ID: 22921304 [Abstract] [Full Text] [Related]